%0 Figure %A Zheng, Ming-Hua %A Seto, Wai-Kay %A Shi, Ke-Qing %A Ka-Ho Wong, Danny %A Fung, James %A Fan-Ngai Hung, Ivan %A Yee-Tak Fong, Daniel %A Chi-Hang Yuen, John %A Tong, Teresa %A Lai, Ching-Lung %A Yuen, Man-Fung %D 2014 %T Schematic representation of the artificial neural network developed to predict A) HBsAg seroclearance and B) HBsAg seroconversion. %U https://plos.figshare.com/articles/figure/_Schematic_representation_of_the_artificial_neural_network_developed_to_predict_A_HBsAg_seroclearance_and_B_HBsAg_seroconversion_/1052242 %R 10.1371/journal.pone.0099422.g001 %2 https://plos.figshare.com/ndownloader/files/1528724 %K Gastroenterology and hepatology %K Liver diseases %K Infectious hepatitis %K Hepatitis B %K neural %K developed %K hbsag %K seroclearance %X

Note: qHBsAg, 3 years before baseline; HBV DNA, 3 years before baseline; qHBsAg reduction, 3 to 2 years before baseline; HBV DNA reduction, 3 to 2 years before baseline.

%I PLOS ONE